Viewing Study NCT00146900



Ignite Creation Date: 2024-05-05 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00146900
Status: COMPLETED
Last Update Posted: 2016-02-19
First Post: 2005-09-04

Brief Title: Prevention of Post Traumatic Stress Disorder by Early Treatment
Sponsor: Hadassah Medical Organization
Organization: Hadassah Medical Organization

Study Overview

Official Title: Prevention of Post Traumatic Stress Disorder by Early Treatment
Status: COMPLETED
Status Verified Date: 2016-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To prospectively evaluate the effect of early treatment cognitive therapy CT cognitive-behavioral therapy CBT and escitalopram SSRI in preventing the occurrence of post-traumatic stress disorder in recent survivors of traumatic events
Detailed Description: Consecutive civilian trauma survivors will be contacted by phone within five days of admission to Hadassah University Hospital in Jerusalem and asked about their early psychological responses to the event A short telephone interview will be administered to consenting subjects to evaluate the presence of acute stress disorder ASD Subjects with ASD full or partial and those who so desire will be invited to clinical assessment which will take place within the next two weeks Survivors with significant symptoms of post-traumatic stress disorder will be randomized to five arms of twelve-week long treatment CBT CT SSRIplacebo and waiting list WL and start treatment immediately Subjects will be allowed to decline one form of therapy WL subjects will start therapy 12 weeks later All subjects who had clinical interview will be interviewed again at four and seven months - and 14 months following trauma phone interview

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
MH- None None None